(Q43056416)

13 November 2017

title

Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease (English)

1 reference

13 November 2017

0 references

1 reference

R Ramajayam

1

1 reference

13 November 2017

Kian-Pin Tan

series ordinal

2

1 reference

13 November 2017

Hun-Ge Liu

series ordinal

3

1 reference

13 November 2017

Po-Huang Liang

series ordinal

4

1 reference

13 November 2017

language of work or name

English

0 references

publication date

20 May 2010

1 reference

Bioorganic & Medicinal Chemistry Letters

13 November 2017

published in

1 reference

13 November 2017

volume

20

1 reference

13 November 2017

issue

12

1 reference

13 November 2017

page(s)

3569-3572

1 reference

A novel coronavirus associated with severe acute respiratory syndrome

13 November 2017

cites work

1 reference

12 December 2020

Development of Broad-Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro

1 reference

12 December 2020

Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors

1 reference

12 December 2020

Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease

1 reference

12 December 2020

A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods

1 reference

12 December 2020

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

1 reference

12 December 2020

Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease

1 reference

12 December 2020

Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.

1 reference

12 December 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

12 December 2020

New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors

1 reference

12 December 2020

Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.

1 reference

12 December 2020

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

1 reference

12 December 2020

Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

1 reference

12 December 2020

Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors

1 reference

12 December 2020

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

1 reference

12 December 2020

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors

1 reference

12 December 2020

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Individual and common inhibitors of coronavirus and picornavirus main proteases

1 reference

12 December 2020

Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors

1 reference

12 December 2020

Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors

1 reference

12 December 2020

Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro

1 reference

12 December 2020

Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

1 reference

12 December 2020

10.1016/J.BMCL.2010.04.118

Identifiers

DOI

1 reference

13 November 2017

0 references

0 references

1 reference